Newly reported from the UK: Prostate MRI Has Independent Screening Value

Prostate magnetic resonance imaging (MRI) has a value for screening independent of prostate-specific antigen (PSA), according to a study published online Aug. 21 in BMJ Oncology.

Caroline M. Moore, M.D., from University College London, and colleagues reported a systematic community-based assessment of the prevalence of prostate MRI lesions among men aged 50 to 75 years. Men were identified from eight participating general practitioner practices and were randomly selected for invitation to a screening MRI and PSA. The U.K. Standard National Health Service (NHS) prostate cancer assessment was recommended for those with a positive MRI or elevated PSA density.

Source: Advances and More licensed by HealthDay